Company / Operating Income per Share
Bicara Therapeutics Inc. Operating Income per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.00
FY2024
5-year range
-$0.07 / -$0.00
FY2023-FY2024
Trend
+92.9%
vs FY2023
Sector context
#56 of 201
Health Care
What the data says
At $-0.00, Bicara Therapeutics Inc.'s operating income per share ranks #56 of 201 in the Health Care sector.
Based on SEC 10-K filings.
-0.00 in FY2024.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#56 of 201 in Health CareTop 28% of 201This company -$0.00 Sector average -$3.23
▼
+99.8% above sector average
Key checks
Key Insights
- In FY2024, operating income per share increased 92.9% year-over-year.
- Ranks #56 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.00 | +92.9% |
| FY2023 | -$0.07 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026